What is Dulaglutide?
Dulaglutide is a GLP-1 receptor agonist marketed as Trulicity. It is FDA-approved for the treatment of type 2 diabetes and is given as a once-weekly injection.
It is primarily a diabetes medication rather than a dedicated weight-management product, though some patients experience modest weight effects.
How it is thought to work
Dulaglutide supports insulin release when blood sugar is high, lowers glucagon, and slows digestion, helping improve glucose control through the week with convenient weekly dosing.
What the research shows
The REWIND trial reported cardiovascular risk reduction in people with type 2 diabetes, supporting dulaglutide's use beyond blood-sugar control alone.
We summarize published research and do not make therapeutic promises. A licensed provider can evaluate whether any therapy is appropriate for you. Treat any source promising guaranteed results with skepticism.
Approved uses
- Blood-sugar control in type 2 diabetes
- Cardiovascular risk reduction in eligible patients
- Weekly dosing convenience
Availability
Dulaglutide is FDA-approved and available now by prescription. It does not depend on the 2026 peptide review.
How to access Dulaglutide legitimately
A licensed provider confirms a qualifying diagnosis and prescribes the branded product through a licensed pharmacy.
PeptideForward can match you with vetted telehealth providers who handle these therapies through legitimate channels. The eligibility check takes about five minutes and there is no cost to see if you are a candidate.
Frequently asked questions
Is dulaglutide used for weight loss? Its approved use is type 2 diabetes. Some patients see modest weight changes, but it is not approved as a weight-management drug. A provider can advise on the right option for your goal.
Is it available now? Yes. It is FDA-approved and prescribable today for patients who qualify.
Does PeptideForward sell it? No. We connect you with licensed providers only.